Pangenomic Health Inc. operates as a precision health company. It develops the Nara App, a mental health app provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; Mindleap, a telehealth platform curates a variety of tools and resources to help individuals understand and improve their inner wellness; and MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports. The company was formerly known as Zetta Capital Corp. and changed its name to Pangenomic Health Inc. in December 2021. The company was incorporated in 2015 and is based in Vancouver, Canada.